This article examines the relevance of applying the Enhanced Recovery after Surgery
(ERAS) approach to patients undergoing major spinal surgery. The history of ERAS, details …

Perioperative bleeding and postsurgical hemorrhage are common in invasive surgical
procedures, including orthopedic surgery. Tranexamic acid (TXA) is a pharmacologic agent …

Background A growing body of published research on tranexamic acid (TXA) suggests that it
is effective in reducing blood loss and the risk for transfusion in total knee arthroplasty (TKA) …

Background The optimal dosage and timing of tranexamic acid (TXA) in total knee
arthroplasty (TKA) are undetermined. The purpose of this study was to explore the effect of …

Background: Tourniquet use during primary total knee arthroplasty is thought to reduce
intraoperative blood loss and improve visibility. Our goal was to investigate whether …

Perioperative blood loss is a significant concern for patients undergoing total joint
arthroplasty. A growing body of evidence has shown tranexamic acid (TXA) to be effective in …

Rates of peri-prosthetic joint infection (PJI) in primary total hip and total knee arthroplasty
range between 0.3% and 1.9%, and up to 10% in revision cases. Significant morbidity is …

Background Tranexamic acid (TXA) has demonstrated efficacy in reducing blood loss,
reduction in hemoglobin, and blood transfusion requirements in primary total hip …

Background: Tranexamic acid is an antifibrinolytic that has been shown to reduce blood loss
and the need for transfusions when administered intravenously in total hip arthroplasty. Oral …

Background The mode of administration for tranexamic acid (TXA) to significantly reduce the
decrease in hemoglobin (Hb), number of transfusions, relevant costs, and side effects in …